Are you Dr. Fitzhugh?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 44 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
600 N Wolfe St
Cmsc-800
Baltimore, MD 21287Phone+1 410-644-5055Fax+1 410-955-0028
Summary
- Dr. Courtney Fitzhugh, MD is a pediatric hematologist/oncologist in Baltimore, Maryland. She is currently licensed to practice medicine in Maryland and North Carolina.
Education & Training
Johns Hopkins UniversityFellowship, Pediatric Hematology/Oncology, 2006 - 2009
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2005 - 2008
Duke University HospitalResidency, Internal Medicine/Pediatrics, 2001 - 2005
University of California San Francisco School of MedicineClass of 2001
Certifications & Licensure
MD State Medical License 2005 - 2026
NC State Medical License 2001 - 2005- American Board of Internal Medicine Hematology
Clinical Trials
- Evaluation of Toxicity From Stem Cell Transplant Start of enrollment: 2008 Feb 29
- Haploidentical PBMC Transplant for Severe Congenital Anemias Start of enrollment: 2009 Dec 14
- Assessment of Algorithm-Based Hydroxyurea Dosing on Fetal Hemoglobin Response, Acute Complications, and Organ Function in People With Sickle Cell Disease Start of enrollment: 2014 Aug 23
- Join now to see all
Publications & Presentations
PubMed
- A machine learning-based workflow for predicting transplant outcomes in patients with sickle cell disease.Haiou Li, Vandana Sachdev, Xin Tian, My-Le Nguyen, Matthew Hsieh
British Journal of Haematology. 2024-10-22 - Pulmonary Function after Nonmyeloablative Hematopoietic Cell Transplant for Sickle Cell Disease.A Parker Ruhl, Ruba Shalhoub, Neal Jeffries, Emily M Limerick, Alexis Leonard
Annals of the American Thoracic Society. 2024-10-01 - TP53 mutation screening for patients at risk of myeloid malignancy.Devdeep Mukherjee, Rialnat A Lawal, Courtney D Fitzhugh, Christopher S Hourigan, Laura W Dillon
Leukemia. 2024-07-01
Press Mentions
ASH: Consider Marrow Transplant for Sickle Cell KidsDecember 8th, 2019
Ongoing Research Aims to Improve Transplant Outcomes in Sickle CellSeptember 26th, 2019
Sickle Cell Disease: No Longer the Road Less TravelledDecember 4th, 2018- Join now to see all
